TCNNF·89788C104·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
TCNNF (Trulieve Cannabis Corporation) is held by 0 institutional investors as of Q3 2022.
See how TCNNF's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer